: GWPH shareholders received $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS).
: Integration of GW has diversified Jazz's neuroscience portfolio, with Epidiolex contributing significantly to its revenue. Current Market Data for Jazz Pharmaceuticals (JAZZ)
Monitor institutional holdings and earnings reports on .
As of late April 2026, Jazz Pharmaceuticals continues to trade on the NASDAQ. You can track its performance on major financial platforms: View real-time quotes on . Check analyst ratings and fair value on Investing.com .
: The deal was valued at approximately $7.2 billion .
: Following the close of the transaction on May 5, 2021 , GWPH shares were delisted from the NASDAQ. How to Invest in GW Pharmaceuticals' Legacy
: GWPH shareholders received $200.00 in cash and $20.00 in Jazz ordinary shares for each GW American Depositary Share (ADS).
: Integration of GW has diversified Jazz's neuroscience portfolio, with Epidiolex contributing significantly to its revenue. Current Market Data for Jazz Pharmaceuticals (JAZZ)
Monitor institutional holdings and earnings reports on .
As of late April 2026, Jazz Pharmaceuticals continues to trade on the NASDAQ. You can track its performance on major financial platforms: View real-time quotes on . Check analyst ratings and fair value on Investing.com .
: The deal was valued at approximately $7.2 billion .
: Following the close of the transaction on May 5, 2021 , GWPH shares were delisted from the NASDAQ. How to Invest in GW Pharmaceuticals' Legacy
Seek urgent assistance from our security operations center! Implement the recommended actions without delay while we address the situation.